"What happens after stopping an obesity medication is exactly what happens after stopping a diabetes, cholesterol-lowering, or a blood pressure medication," he told ABC News
What the advisory says The regulator named semaglutide products including Ozempic, Rybelsus and Wegovy, as well as tirzepatide products Mounjaro and Zepbound, as the authorized GLP-1 products in Canada [Source: newswire.ca/news-releases/public-advisory-thinking-about-buying-glp-1-drugs-like-ozempic-or-mounjaro-beware-of-fake-or-unauthorized-products-844970747.html]
That balancing act is not something an article can do for you, and its not something your surgeon can do without your prescriber either
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact
Neither outcome is acceptable when the math is this straightforward
But more recently, other weight-loss medications such as Wegovy (semaglutide) have hit the market, too